Cargando…

Development of cancer prognostic signature based on pan-cancer proteomics

Utilizing genomic data to predict cancer prognosis was insufficient. Proteomics can improve our understanding of the etiology and progression of cancer and improve the assessment of cancer prognosis. And the Clinical Proteomic Tumor Analysis Consortium (CPTAC) has generated extensive proteomics data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Weiguo, Chen, Jianhui, Weng, Wanqing, Xiang, Yukai, Shi, Hongqi, Shan, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291886/ https://www.ncbi.nlm.nih.gov/pubmed/33200655 http://dx.doi.org/10.1080/21655979.2020.1847398

Ejemplares similares

Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

Prognostic and immunological role of CD36: A pan-cancer analysis
por: Chen, Yong-Jian, et al.
Publicado: (2021)

Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma
por: Kotol, David, et al.
Publicado: (2023)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

Establishment and Validation of an Interferon-Stimulated Genes (ISGs) Prognostic Signature in Pan-cancer Patients: A Multicenter, Real-world Study
por: Zhou, Zheng, et al.
Publicado: (2022)

A two-gene-based prognostic signature for pancreatic cancer
por: Zhou, Shuyi, et al.
Publicado: (2020)

Pan-Cancer Pyroptosis Analyses Identified Novel Immunology and Chemotherapy-Related Prognostic Signatures in Cancer Subtypes
por: Li, Canrong, et al.
Publicado: (2022)

Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer
por: Dai, Zhou-Tong, et al.
Publicado: (2021)

Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer
por: Yang, Kaixin, et al.
Publicado: (2022)

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
por: Shen, Sipeng, et al.
Publicado: (2018)

Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer
por: Zhang, Qian, et al.
Publicado: (2020)

A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence
por: Wu, Zhengquan, et al.
Publicado: (2023)

Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
por: Morris, Luc G.T., et al.
Publicado: (2016)

DNA hypomethylation mediates immune response in pan-cancer
por: Zhang, Chunlong, et al.
Publicado: (2023)

Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer
por: Chen, Yun, et al.
Publicado: (2021)

A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance
por: Yang, Longfei, et al.
Publicado: (2023)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

An immunogenomic signature for molecular classification in hepatocellular carcinoma
por: Zhuang, Weiwei, et al.
Publicado: (2021)

Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma
por: Weng, Wanqing, et al.
Publicado: (2020)

Correction to: Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma
por: Weng, Wanqing, et al.
Publicado: (2020)

Pan-metastatic cancer analysis of prognostic factors and a prognosis-based metastatic cancer classification system
por: Zhang, Chao, et al.
Publicado: (2020)

Development and validation of an individual alternative splicing prognostic signature in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Pan-Cancer Identification of Prognostic-Associated Metabolic Pathways
por: Chen, Wenbo, et al.
Publicado: (2023)

A pan-cancer proteomic perspective on The Cancer Genome Atlas
por: Akbani, Rehan, et al.
Publicado: (2014)

Development of prognostic signature and nomogram for patients with breast cancer
por: Su, Jiao, et al.
Publicado: (2019)

Towards a potential pan-cancer prognostic signature for gene expression based on probesets and ensemble machine learning
por: Chicco, Davide, et al.
Publicado: (2022)

A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers
por: Gu, Yuxi, et al.
Publicado: (2021)

Immunological Role and Prognostic Value of APBB1IP in Pan-Cancer Analysis
por: Ge, Qianyun, et al.
Publicado: (2021)

Comprehensive pan-cancer analysis reveals the prognostic value and immunological role of SPIB
por: Ding, Meng, et al.
Publicado: (2022)

A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer
por: Gao, Xiaofeng, et al.
Publicado: (2023)

Personalizing prognostic prediction in early-onset Colorectal Cancer
por: Liu, Jian, et al.
Publicado: (2020)

RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers
por: Jones, Wendell D., et al.
Publicado: (2020)

Pan-cancer analysis on microRNA-associated gene activation
por: Tan, Hua, et al.
Publicado: (2019)

Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
por: Luo, Li-Zhi, et al.
Publicado: (2023)

Development of a Novel Autophagy-related Prognostic Signature for Serous Ovarian Cancer
por: An, Yuanyuan, et al.
Publicado: (2018)

Development of a 7-miRNA prognostic signature for patients with bladder cancer
por: Xv, Yingjie, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic value of C12orf75 based on data mining
por: Cai, Guangzhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5nnh6oloi67phtah875l57963u